- A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.- A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients. https://www.nytimes.com/2019/05/13/opinion/truvada-gilead-hiv-trump.html 6 comments politics
Linked pages
- Gilead profits from Tuvada HIV treatment funded by taxpayers and patented by the U.S. government - The Washington Post https://www.washingtonpost.com/business/economy/pharma-giant-profits-from-hiv-treatment-funded-by-taxpayers-and-patented-by-the-government/2019/03/26/cee5afb4-40fc-11e9-9361-301ffb5bd5e6_story.html 86 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: Opinion | A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them. - The New York Times
See how to search.